Gao et al. conducted expression and functional analyses of DPYSL3 in prostate cancer and found that DPYSL3 is a metastasis suppressor that is inversely associated with the expression of vascular endothelial growth factor (VEGF) [14]. This evidence concerns the gene DPYSL3 and prostate carcinoma.